AstraZeneca's Deals Prompt Doubts About Quality

U.K. pharmaceutical company AstraZeneca is doing deals to help bolster near-term revenues, potentially at the cost of future earnings.

via WSJ.com: Markets http://ift.tt/1bpgbRd